LD 2139

  • Maine House Bill
  • 131st Legislature (2023-2024)
  • Introduced in House
  • Passed House Mar 05, 2024
  • Passed Senate Mar 06, 2024
  • Signed by Governor Mar 14, 2024

An Act To Add Schedule V Substances To The Controlled Substances Prescription Monitoring Program

Votes


No votes to display

Actions


Mar 14, 2024

Office of the Governor

Signed by Governor

Mar 06, 2024

Senate

PASSED TO BE ENACTED, in concurrence.

Mar 05, 2024

House

PASSED TO BE ENACTED.

House

Sent for concurrence. ORDERED SENT FORTHWITH.

Feb 29, 2024

Senate

Ordered sent down forthwith

Senate

COMMITTEE ON BILLS IN THE SECOND READING REPORTS NO FURTHER VERBAL AMENDMENTS NECESSARY. REPORT ACCEPTED.

Senate

READ A SECOND TIME and PASSED TO BE ENGROSSED, in concurrence.

Feb 28, 2024

Senate

ASSIGNED FOR SECOND READING NEXT LEGISLATIVE DAY.

Senate

Report READ and ACCEPTED

Senate

READ ONCE

Feb 27, 2024

House

Sent for concurrence. ORDERED SENT FORTHWITH.

House

CONSENT CALENDAR - FIRST DAY

House

Under suspension of the rules CONSENT CALENDAR - SECOND DAY.

House

The Bill was PASSED TO BE ENGROSSED.

Feb 23, 2024

Maine Legislature

Reported Out - OTP

Feb 15, 2024

Maine Legislature

Work Session Held

Maine Legislature

Voted - OTP

Jan 09, 2024

Senate

The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES in concurrence

Jan 03, 2024

House

Sent for concurrence. ORDERED SENT FORTHWITH.

House

The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES.

House

Committee on Health and Human Services suggested and ordered printed.

Bill Text

Bill Text Versions Format
Documents and Disposition PDF
Final Disposition PDF

Related Documents

Document Format
Final Disposition - Fiscal Note HTML HTML
Final Disposition - Fiscal Note PDF PDF
Documents and Disposition - Fiscal Note HTML HTML
Documents and Disposition - Fiscal Note PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maine Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.